UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 4.963

Sortiert nach

Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance

Gynecologic oncology, 2015-02, Vol.136 (2), p.178-182

2015

Link zum Volltext

Verfügbarkeit prüfen

Highlights from the Society of Gynecologic Oncology 2017 Annual Meeting on Women's Cancer

Gynecologic oncology, 2017-06, Vol.145 (3), p.483-485

2017

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix” [Gynecol. Oncol. 145 (2017) 284–290]

Gynecologic oncology, 2017-08, Vol.146 (2), p.440-440

2017

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to ‘Tumor diameter as a predictor of lymphatic dissemination in endometrioid endometrial cancer’ [Gynecol. Oncol. 141 (2016) 199–205]

Gynecologic oncology, 2017-03, Vol.144 (3), p.649-649

2017

Link zum Volltext

Verfügbarkeit prüfen

Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A Trans PORTEC initiative

Gynecologic oncology, 2017-08, Vol.146 (2), p.327-333

2017

Link zum Volltext

Verfügbarkeit prüfen

Patterns of care for FIGO stage IB-IIA cervical cancer across the United States

Gynecologic oncology, 2017-06, Vol.145, p.181-181

2017

Link zum Volltext

Verfügbarkeit prüfen

Change in genetics service model increases ovarian cancer patient referrals and decreases time to consultation: Improving compliance with guideline-based quality care

Gynecologic oncology, 2017-06, Vol.145, p.165-166

2017

Link zum Volltext

Verfügbarkeit prüfen

A SEER-Medicare analysis of the impact of metformin on overall survival in ovarian cancer patients

Gynecologic oncology, 2017-06, Vol.145, p.146-147

2017

Link zum Volltext

Verfügbarkeit prüfen

The impact of ovarian cancer spread on survival in advanced epithelial ovarian cancer: A cohort study

Gynecologic oncology, 2017-06, Vol.145, p.131-132

2017

Link zum Volltext

Verfügbarkeit prüfen

A cost comparison of resource utilization before and after implementing an enhanced recovery program (ERP): A significant impact on the ‘bottom line’

Gynecologic oncology, 2017-06, Vol.145, p.137-137

2017

Link zum Volltext

Verfügbarkeit prüfen

Antioxidant gene expression program is deregulated early in serous ovarian cancer

Gynecologic oncology, 2017-06, Vol.145, p.130-130

2017

Link zum Volltext

Verfügbarkeit prüfen

A preoperative algorithm for the management of primary ovarian cancer: A process and outcome evaluation

Gynecologic oncology, 2017-06, Vol.145, p.65-65

2017

Link zum Volltext

Verfügbarkeit prüfen

Obesity-driven metabolic effects differ in ovarian vs endometrial cancer

Gynecologic oncology, 2017-06, Vol.145, p.34-35

2017

Link zum Volltext

Verfügbarkeit prüfen

Postoperative complications and survivorship trends following ovarian cancer surgery in New York state

Gynecologic oncology, 2017-06, Vol.145, p.168-168

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of consistent intraoperative assessment on predicting tumor size, myometrial invasion, and cervical involvement: Results from an observational cohort

Gynecologic oncology, 2017-06, Vol.145, p.192-192

2017

Link zum Volltext

Verfügbarkeit prüfen

Is VTE chemoprophylaxis beneficial after robotic hysterectomy with staging for uterine cancer? An analysis of prevalence, prophylaxis and Caprini risk assessment model among 332 patients

Gynecologic oncology, 2017-06, Vol.145, p.141-142

2017

Link zum Volltext

Verfügbarkeit prüfen

Histone deacetylase inhibitor MS-275 potentiates cisplatin toxicity in epithelial ovarian cancer

Gynecologic oncology, 2017-06, Vol.145, p.131-131

2017

Link zum Volltext

Verfügbarkeit prüfen

An analysis of efficacy and safety of olaratumab + doxorubicin or doxorubicin alone in patients with uterine leiomyosarcoma: A retrospective assessment of the phase 1b/2 study JGDG

Gynecologic oncology, 2017-06, Vol.145, p.93-93

2017

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant chemotherapy vs primary debulking surgery: A propensity score matched cohort analysis of survival

Gynecologic oncology, 2017-06, Vol.145, p.68-68

2017

Link zum Volltext

Verfügbarkeit prüfen

Urinary bisphenol a levels in women with endometrial cancer

Gynecologic oncology, 2017-06, Vol.145, p.110-111

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of progestin therapy for endometrial cancer in morbidly obese patients

Gynecologic oncology, 2017-06, Vol.145, p.164-165

2017

Link zum Volltext

Verfügbarkeit prüfen

Genetic and therapeutic inhibition of the receptor tyrosine kinase AXL restores paclitaxel chemosensitivity in uterine serous cancer

Gynecologic oncology, 2017-06, Vol.145, p.77-78

2017

Link zum Volltext

Verfügbarkeit prüfen

Hospital readmission as a quality measure in ovarian cancer surgery

Gynecologic oncology, 2017-06, Vol.145, p.4-5

2017

Link zum Volltext

Verfügbarkeit prüfen

Pathologic response differs between and within tumor sites at the time of interval debulking surgery following neoadjuvant chemotherapy in advanced ovarian cancer

Gynecologic oncology, 2017-06, Vol.145, p.104-104

2017

Link zum Volltext

Verfügbarkeit prüfen

Robotic surgery in the management of uterine cancer: An Australian experience

Gynecologic oncology, 2017-06, Vol.145, p.184-184

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 4.963

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

ThemaScience & Technology

ThemaHematology, Oncology And Palliative Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.816)
Mit Volltextzugriff
(4.921)

Publikationsform

Artikel
(4.915)
Buchkapitel
(42)
Reviews
(6)

Sprache

Englisch
(4.963)
Japanisch
(50)

Erscheinungsjahr

n.n

Thema

Obstetrics And Gynecology
(4.962)
Humans
(182)
Female
(175)
Case Report
(148)
Middle Aged
(81)
Adult
(71)
Oncology
(61)
Aged
(59)
Ovarian Cancer
(56)
Neoplasm Staging
(38)
Breast Neoplasms - Pathology
(37)
Prognosis
(36)
Cervical Cancer
(32)
Chemotherapy
(30)
Disease-Free Survival
(26)
Aged, 80 And Over
(25)
Breast Neoplasms - Drug Therapy
(24)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(23)
Treatment Outcome
(23)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Gynecologic Oncology
(4.345)
Clinical Breast Cancer
(226)
Gynecologic Oncology Case Reports
(168)
Clinical Ovarian Cancer And Other Gynecologic Malignancies
(105)
Clinical Ovarian & Other Gynecologic Cancer
(45)
Gynecologic Oncology Reports
(31)
Clinical Ovarian Cancer
(1)
Thrombosis Research
(1)

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance

Highlights from the Society of Gynecologic Oncology 2017 Annual Meeting on Women's Cancer

Corrigendum to “comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix” [Gynecol. Oncol. 145 (2017) 284–290]

Corrigendum to ‘Tumor diameter as a predictor of lymphatic dissemination in endometrioid endometrial cancer’ [Gynecol. Oncol. 141 (2016) 199–205]

Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A Trans PORTEC initiative

Patterns of care for FIGO stage IB-IIA cervical cancer across the United States

Change in genetics service model increases ovarian cancer patient referrals and decreases time to consultation: Improving compliance with guideline-based quality care

A SEER-Medicare analysis of the impact of metformin on overall survival in ovarian cancer patients

The impact of ovarian cancer spread on survival in advanced epithelial ovarian cancer: A cohort study

A cost comparison of resource utilization before and after implementing an enhanced recovery program (ERP): A significant impact on the ‘bottom line’

Antioxidant gene expression program is deregulated early in serous ovarian cancer

A preoperative algorithm for the management of primary ovarian cancer: A process and outcome evaluation

Obesity-driven metabolic effects differ in ovarian vs endometrial cancer

Postoperative complications and survivorship trends following ovarian cancer surgery in New York state

Impact of consistent intraoperative assessment on predicting tumor size, myometrial invasion, and cervical involvement: Results from an observational cohort

Is VTE chemoprophylaxis beneficial after robotic hysterectomy with staging for uterine cancer? An analysis of prevalence, prophylaxis and Caprini risk assessment model among 332 patients

Histone deacetylase inhibitor MS-275 potentiates cisplatin toxicity in epithelial ovarian cancer

An analysis of efficacy and safety of olaratumab + doxorubicin or doxorubicin alone in patients with uterine leiomyosarcoma: A retrospective assessment of the phase 1b/2 study JGDG

Neoadjuvant chemotherapy vs primary debulking surgery: A propensity score matched cohort analysis of survival

Urinary bisphenol a levels in women with endometrial cancer

Efficacy of progestin therapy for endometrial cancer in morbidly obese patients

Genetic and therapeutic inhibition of the receptor tyrosine kinase AXL restores paclitaxel chemosensitivity in uterine serous cancer

Hospital readmission as a quality measure in ovarian cancer surgery

Pathologic response differs between and within tumor sites at the time of interval debulking surgery following neoadjuvant chemotherapy in advanced ovarian cancer

Robotic surgery in the management of uterine cancer: An Australian experience

Aktive Filter

Suchergebnisse filtern